MARCAINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Marcaine Hydrochloride, and what generic alternatives are available?
Marcaine Hydrochloride is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in MARCAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for MARCAINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Clinical Trials: | 280 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MARCAINE HYDROCHLORIDE |
DailyMed Link: | MARCAINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MARCAINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johnny K. Lee | Phase 4 |
NorthShore University HealthSystem | Phase 4 |
Abant Izzet Baysal University | Phase 4 |
Pharmacology for MARCAINE HYDROCHLORIDE
Drug Class | Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |